Press Release (ePRNews.com) - New York,NY, USA - Nov 28, 2018 - Soterix Medical Inc. announces receipt of allowance of claims from the U.S. Patent Office for an application covering advanced electrodes for all forms of non-invasive electrical stimulation including transcranial Direct Current Stimulation (tDCS). Soterix Medical is the established leader in applied non-invasive brain stimulation technology including the most advanced electrodes. Electrodes technology is essential for effective neuromodulation therapy providing Soterix Medical devices with unmatched performance. The claims cover hybrid magnetic-electro electrodes that complement the existing Soterix Medical state-of-the-art electrode technology portfolio. This additional patent confirms Soterix Medical’s patent portfolio as the strongest in the non-invasive neuromodulation industry.
As described by Mr. Mithlesh Dev, Senior Development Engineer, “For a decade, Soterix Medical has set the standard for electrode technology including creating High-Definition (HD) electrodes for HD-tDCS, the only platform for focal transcranial stimulation. The development of magneto-electrodes is yet another new category of electrode technology designed for deployability and efficacy.”
Dr. Abhishek Datta, CTO of Soterix Medical continues, “This patent continues to build on our success in securing intellectual property for our unique product and services pipeline targeted toward neurological and neuropsychiatric disorders. Soterix Medical products stand far apart and ahead of competing systems because we continuously innovate and deploy new electrode technologies. This is why researchers and clinicians trust Soterix Medical devices to provide best-in-class performance across product categories.”
CAUTION: tDCS and HD-tDCS is limited by Federal (or United States) law to investigational use only.
Contact: Kamran Nazim Source :